Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_21152 | 8 | 0.17 | Mlig455_014619 | Neo: - Age: - |
Mlig455_014619 {REF} {Length: 330} {NoTransDecoderORF} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | - | - | - | - | |
RegionR2 | - | - | - | - | |
RegionR3 | - | - | - | - | |
RegionR4 | - | - | - | - | |
RegionR5 | - | - | - | - | |
RegionR6 | - | - | - | - | |
RegionR7 | - | - | - | - | |
RegionR8 | - | - | - | - |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | - | - | - | - | |
RegenerationR2 | - | - | - | - | |
RegenerationR3 | - | - | - | - | |
RegenerationR4 | - | - | - | - | |
RegenerationR5 | - | - | - | - | |
RegenerationR6 | - | - | - | - | |
RegenerationBL | - | - | - | - | |
RegenerationTP | - | - | - | - |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_21152 | 8 | 0.17 | Mlig455_014619 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_014619 {REF} {Length: 330} {NoTransDecoderORF} | |
2. | MligTC455_00248 | 12 | 0.25 | Mlig455_022926 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_022926 {REF} {Length: 481} {NoTransDecoderORF} | |
3. | MligTC455_36944 | 22 | 0.45 | Mlig455_065298, Mlig455_065320 | Neo: - Age: Up-Down-Up |
NR2F1 | 0.997 | - | - | - | - | 0.997 | - | Mlig455_065298 {REF} {Length: 2485} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=100.7]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=95.1]} {Human: ENSG00000175745, NR2F1, nuclear receptor subfamily 2 group F member 1, [RH, Score=241, Expect=4e-73]; ENSG00000185551, NR2F2, nuclear receptor subfamily 2 group F member 2, [RH, Score=240, Expect=2e-72]} {Mouse: ENSMUSG00000069171, Nr2f1, nuclear receptor subfamily 2, group F, member 1, [RH, Score=240, Expect=2e-72]; ENSMUSG00000030551, Nr2f2, nuclear receptor subfamily 2, group F, member 2, [RH, Score=240, Expect=1e-72]} {Dmel: FBgn0003651, svp, seven up, [RH, Score=240, Expect=3e-71]} {Celegans: WBGene00006790, unc-55, UNC-55b isoform, [RH, Score=150, Expect=4e-40]} {Smed: dd_Smed_v6_33286_0_1, dd_Smed_v6_33286_0_1, [RH, Score=211, Expect=4e-61]} Mlig455_065320 {REF} {Length: 3080} {Pfam: Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=76.1]} {Human: ENSG00000175745, NR2F1, nuclear receptor subfamily 2 group F member 1, [Score=215, Expect=6e-67]; ENSG00000185551, NR2F2, nuclear receptor subfamily 2 group F member 2, [Score=214, Expect=5e-66]} {Mouse: ENSMUSG00000069171, Nr2f1, nuclear receptor subfamily 2, group F, member 1, [Score=215, Expect=2e-68]; ENSMUSG00000030551, Nr2f2, nuclear receptor subfamily 2, group F, member 2, [Score=214, Expect=4e-66]} {Dmel: FBgn0003651, svp, seven up, [Score=211, Expect=2e-66]} {Celegans: WBGene00006790, unc-55, UNC-55b isoform, [Score=69.3, Expect=4e-13]} {Smed: dd_Smed_v6_33286_0_1, dd_Smed_v6_33286_0_1, [Score=183, Expect=9e-54]} |
4. | MligTC455_11282 | 124 | 2.58 | Mlig455_017457, Mlig455_030936 | Neo: - |
FDXACB1 | 0.989 | - | - | - | - | 0.989 | - | Mlig455_017457 {REF} {Length: 3560} {Pfam: Domain of unknown function (DUF2431) [PF10354.11, score=97.3]; Ferredoxin-fold anticodon binding domain [PF03147.16, score=28.8]} {Human: ENSG00000255561, FDXACB1, ferredoxin-fold anticodon binding domain containing 1, [RH, Score=97.4, Expect=1e-20]} {Mouse: ENSMUSG00000037845, Fdxacb1, ferredoxin-fold anticodon binding domain containing 1, [RH, Score=104, Expect=4e-23]} {Celegans: WBGene00012768, eef-1B.2, Probable elongation factor 1-beta/1-delta 2, [RH, Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_12236_0_1, dd_Smed_v6_12236_0_1, [RH, Score=98.2, Expect=2e-21]} {RNA1509_12220} {RNA1310_10541} {RNA815_15665} Mlig455_030936 {REF} {Length: 2975} {Pfam: Domain of unknown function (DUF2431) [PF10354.11, score=97.3]; Ferredoxin-fold anticodon binding domain [PF03147.16, score=29.2]} {Human: ENSG00000255561, FDXACB1, ferredoxin-fold anticodon binding domain containing 1, [RH, Score=97.4, Expect=2e-20]} {Mouse: ENSMUSG00000037845, Fdxacb1, ferredoxin-fold anticodon binding domain containing 1, [RH, Score=104, Expect=6e-23]} {Celegans: WBGene00012768, eef-1B.2, Probable elongation factor 1-beta/1-delta 2, [RH, Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_12236_0_1, dd_Smed_v6_12236_0_1, [RH, Score=98.2, Expect=2e-21]} {RNA1310_10541} {RNA815_15665} |
5. | MligTC455_43863 | 3 | 0.07 | Mlig455_037096 | Neo: - Age: - |
0.987 | - | - | - | - | 0.987 | - | Mlig455_037096 {REF} {Length: 407} {NoTransDecoderORF} {RNA1310_68067} {RNA815_39076} | |
6. | MligTC455_17563 | 30 | 0.62 | Mlig455_024249 | Neo: - Age: - |
MEOX1 | 0.976 | - | - | - | - | 0.976 | - | Mlig455_024249 {REF} {Length: 1506} {Pfam: Homeodomain [PF00046.31, score=77.2]} {Human: ENSG00000005102, MEOX1, mesenchyme homeobox 1, [RH, Score=105, Expect=2e-27]; ENSG00000106511, MEOX2, mesenchyme homeobox 2, [RH, Score=104, Expect=1e-26]} {Mouse: ENSMUSG00000001493, Meox1, mesenchyme homeobox 1, [RH, Score=104, Expect=2e-27]; ENSMUSG00000036144, Meox2, mesenchyme homeobox 2, [RH, Score=103, Expect=1e-26]} {Dmel: FBgn0014949, btn, buttonless, [RH, Score=102, Expect=1e-27]} {Celegans: WBGene00000436, ceh-12, Homeobox protein ceh-12, [Score=79.7, Expect=9e-19]} {Smed: dd_Smed_v6_12317_0_1, dd_Smed_v6_12317_0_1, [RH, Score=99.4, Expect=4e-25]} {RNA1310_43427.1} |
7. | MligTC455_00438 | 6 | 0.13 | Mlig455_015467 | Neo: - Age: - |
0.97 | - | - | - | - | 0.970 | - | Mlig455_015467 {REF} {Length: 251} {NoTransDecoderORF} | |
8. | MligTC455_39013 | 53 | 1.1 | Mlig455_030082 | Neo: - Age: Up-Down-Down |
PLCB1 | 0.968 | - | - | - | - | 0.968 | - | Mlig455_030082 {REF} {Length: 5740} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=199.2]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=124.4]; PH domain [PF17787.3, score=120.6]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=33.9]} {Human: ENSG00000182621, PLCB1, phospholipase C beta 1, [RH, Score=826, Expect=0.0]; ENSG00000149782, PLCB3, phospholipase C beta 3, [RH, Score=824, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [RH, Score=826, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [RH, Score=813, Expect=0.0]} {Dmel: FBgn0262738, norpA, no receptor potential A, [Score=670, Expect=0.0]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=680, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_1, dd_Smed_v6_3221_0_1, [Score=724, Expect=0.0]} {RNA1509_47106} {RNA1310_7555, RNA1509_47106} {RNA1509_47106, RNA815_2033} |
9. | MligTC455_06658 | 25 | 0.52 | Mlig455_051229, Mlig455_062996 | Neo: - Age: Up-Down-Down |
0.966 | - | - | - | - | 0.966 | - | Mlig455_051229 {REF} {Length: 1768} {NoTransDecoderORF} {RNA1310_24773} {RNA815_5978} Mlig455_062996 {REF} {Length: 1837} {NoTransDecoderORF} {RNA1310_24773} {RNA815_5978} |
|
10. | MligTC455_07424 | 29 | 0.6 | Mlig455_052614 | Neo: - Age: - |
0.955 | - | - | - | - | 0.955 | - | Mlig455_052614 {REF} {Length: 721} {RNA1310_31171} | |
11. | MligTC455_31813 | 5 | 0.11 | Mlig455_006758, Mlig455_019241 | Neo: - Age: - |
0.955 | - | - | - | - | 0.955 | - | Mlig455_006758 {REF} {Length: 3990} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=122.8]} {Smed: dd_Smed_v6_26484_0_6, dd_Smed_v6_26484_0_6, [Score=68.2, Expect=2e-13]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} Mlig455_019241 {REF} {Length: 2474} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=112.3]} {Smed: dd_Smed_v6_26484_0_6, dd_Smed_v6_26484_0_6, [Score=62.8, Expect=1e-11]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_15609} |